Evidence map›Paper›PMID 32151038›Full record

ArticlePathogens (Basel, Switzerland)2020

Urinary N-acetyltyramine-O,β-glucuronide in Persons with Onchocerciasis

An Hotterbeekx, Alfred Dusabimana, Michel Mandro, Germain M Abhafule, Wonya'Rossy Deogratias, Joseph N Siewe Fodjo, Steven Abrams, Robert Colebunders

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Onchocerciasis-associated epilepsy and biomarkers.PLoS neglected tropical diseases · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

An HotterbeekxGlobal Health Institute, University of Antwerp, B-2610 Wilrijk, Belgium.
Alfred DusabimanaGlobal Health Institute, University of Antwerp, B-2610 Wilrijk, Belgium.
Michel MandroProvincial Health Division Ituri, Ministry of Health, 185 DRC 57 Ituri, Congo.
Germain M AbhafuleProvincial Health Division Ituri, Ministry of Health, 185 DRC 57 Ituri, Congo.
Wonya'Rossy DeogratiasProvincial Health Division Ituri, Ministry of Health, 185 DRC 57 Ituri, Congo.
Joseph N Siewe FodjoGlobal Health Institute, University of Antwerp, B-2610 Wilrijk, Belgium.
Steven AbramsGlobal Health Institute, University of Antwerp, B-2610 Wilrijk, Belgium.
Robert ColebundersGlobal Health Institute, University of Antwerp, B-2610 Wilrijk, Belgium.
University of Antwerp · BE

Funding

European Research Council 671055
6 · The paper itself

Abstract

We investigated urinary N-acetyltyramine-O,β-glucuronide (NATOG) levels as a biomarker for active

Indexed as

AfricabiomarkerN-acetyltyramine-O,β-glucuronide (NATOG), epilepsyOnchocerca volvulusurine

Identifiers

PMID32151038
PMCPMC7157704
OpenAlexW3010032297

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.